EP-1394: SABR for T2 Tumors of Lung
نویسندگان
چکیده
منابع مشابه
Clinical outcome of hypofractionated breath-hold image-guided SABR of primary lung tumors and lung metastases
BACKGROUND Stereotactic Ablative RadioTherapy (SABR) of lung tumors/metastases has been shown to be an effective treatment modality with low toxicity. Outcome and toxicity were retrospectively evaluated in a unique single-institution cohort treated with intensity-modulated image-guided breath-hold SABR (igSABR) without external immobilization. The dose-response relationship is analyzed based on...
متن کاملUnification of T2a and T2b tumors to T2 tumors in non-small cell lung cancer staging.
INTRODUCTION We investigated the validation of the seventh edition of the TNM staging (2009) system for lung cancer, retrospectively. METHODS From January 1990 to March 2004, 1629 patients who underwent lung resection with systemic lymph node dissection for non-small cell lung cancer at Nippon Medical School and Saitama Cancer Center were included. The overall survivals after surgery by each ...
متن کاملPneumomediastinum as a complication of SABR for lung metastases
BACKGROUND Stereotactic ablative body radiation (SABR) is a novel and sophisticated radiation modality that involves the irradiation of extracranial tumors through precise and very high doses in patients with oligometastatic lung disease and primary lung tumors. CASE PRESENTATION A 52-year-old female with subclinical idiopathic interstitial lung disease (ILD) and oligometastatic lung disease ...
متن کاملSABR in early operable lung cancer: time for evidence.
In The Lancet Oncology, Joe Chang and colleagues report the combined results of two randomised trials (STARS and ROSEL) comparing stereotactic ablative radiotherapy (SABR) with surgery for early-stage non-small-cell lung cancer, both of which were halted early because of slow recruitment. We congratulate the investigators for publishing the results and for being prepared to merge their data in ...
متن کاملScalpel or SABR for Treatment of Early-Stage Lung Cancer: Clinical Considerations for the Multidisciplinary Team
Treatment options for early-stage (T1-2 N0) non-small cell lung cancer are often limited by the patient's advanced age, poor performance status, and comorbidities. Despite these challenges, stereotactic ablative radiotherapy (SABR) provides a highly effective and safe therapy for intrathoracic tumors and has become the standard of care for delivering definitive treatment in medically inoperable...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Radiotherapy and Oncology
سال: 2018
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(18)31703-1